Delivery Order SPE2DB22D3016-SPE2DB25FBJZ7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lacosamide 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,351.98 and an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,433.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lacosamide 50 mg/5 mL unit dose vials. This competitively awarded, non-set-aside contract is scheduled for completion by September 18, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200ml quantity, with a ceiling value of $2,681.84 and an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200 ml volume at a ceiling value of $1,022.72. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lacosamide 10 mg/mL Solution in a 200 mL quantity, with a ceiling value of $1,296.57. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The award carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lacosamide 10 mg/ml Solution 200ml, with a ceiling value of $1,002.66 under a firm fixed price contract structure. This competitively awarded delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Lacosamide 100 mg tablets in unit dose packaging (60-count), valued at $2,165.55. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,482.93 to AmerisourceBergen Drug Corp for the supply of Lacosamide 200 mg/20 ml vials. This contract is non-competitive and firm fixed price, with an ultimate completion date of September 12, 2025, just one day after the award date of September 11, 2025. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lacosamide 10 mg/ml solution in a 200ml quantity, with a contract ceiling value of $3,155.52. This award was made on November 3, 2025, with an ultimate completion date of November 4, 2025, under a firm fixed price delivery order with no set-aside designation. The contract represents a competitive award for pharmaceutical procurement to support federal medical supply needs, with performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, for the supply of Lacosamide 100 mg/10 ml cups in unit dose 10 ml vials. The contract, valued at $11,001.30, is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. This award was made without a set-aside designation through competitive procurement by the Defense Logistics Agency's Medical Supply...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJZ7Delivery Order
The Defense Logistics Agency awarded a $2,280.86 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200 ml volume. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. Lacosamide is an anticonvulsant medication used primarily for the treatment of partial-onset seizures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/18/25 |